Shandong Pharmaceutical Glass Co (SHSE:600529) Other Stockholders Equity: ¥3,428 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600529 Shandong Pharmaceutical Glass Co Ltd SHSE:600529
92 GF Score
Price ¥19.37
GF Value ¥24.49
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shandong Pharmaceutical Glass Co Other Stockholders Equity?

Shandong Pharmaceutical Glass Co SHSE:600529 -1.27% 92 Other Stockholders Equity is ¥3,428 Mil as of Mar. 2026. GuruFocus rates SHSE:600529 with a GF Score™ of 92/100 and a GF Value™ of ¥24.49 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Shandong Pharmaceutical Glass Co's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ¥3,428 Mil.

Shandong Pharmaceutical Glass Co's quarterly Other Stockholders Equity declined from Sep. 2025 (¥3,366 Mil) to Dec. 2025 (¥782 Mil) but then increased from Dec. 2025 (¥782 Mil) to Mar. 2026 (¥3,428 Mil).

Shandong Pharmaceutical Glass Co's annual Other Stockholders Equity increased from Dec. 2023 (¥647 Mil) to Dec. 2024 (¥723 Mil) and increased from Dec. 2024 (¥723 Mil) to Dec. 2025 (¥782 Mil).

Shandong Pharmaceutical Glass Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Shandong Pharmaceutical Glass Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Pharmaceutical Glass Co Other Stockholders Equity Chart

Shandong Pharmaceutical Glass Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 524.82 586.22 647.09 722.95 782.33

Shandong Pharmaceutical Glass Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,367.64 720.94 3,365.78 782.33 3,428.08
SHSE:600529
92GF Score
Shandong Pharmaceutical Glass Co Ltd SHSE:600529
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Pharmaceutical Glass Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ¥3,428 Mil mean?
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Other Stockholders Equity of ¥3,428 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Shandong Pharmaceutical Glass Co and its competitors.
Is Shandong Pharmaceutical Glass Co's Other Stockholders Equity too high?
Shandong Pharmaceutical Glass Co's current Other Stockholders Equity is ¥3,428 Mil. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Other Stockholders Equity compare to SW and PKG?
Shandong Pharmaceutical Glass Co's Other Stockholders Equity of ¥3,428 Mil can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Packaging & Containers company?
A good Other Stockholders Equity depends on the Packaging & Containers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Shandong Pharmaceutical Glass Co and its competitors. Shandong Pharmaceutical Glass Co's current Other Stockholders Equity is ¥3,428 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.49, compared to a current price of ¥19.37 — trading 20.9% below its estimated fair value. The current Other Stockholders Equity is ¥3,428 Mil. Shandong Pharmaceutical Glass Co's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Other Stockholders Equity is ¥3,428 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued. The current stock price of ¥19.37 is trading 20.9% below its estimated GF Value™ of ¥24.49. GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.

Key valuation signals for SHSE:600529:

  • Other Stockholders Equity: ¥3,428 Mil
  • GF Value™: ¥24.49 vs. price of ¥19.37 (20.9% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Pharmaceutical Glass Co Business Description

Address Yaobo Road, Yiyuan County, Zibo, Shandong, CHN, 256100
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
92GF Score

Get the complete analysis for SHSE:600529

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.37
Price
¥24.49
GF Value